Real-Time M&A Intelligence for Life Sciences Companies
Track acquisition trends, benchmark your readiness, and generate board-ready reports. Built exclusively for medical device and life sciences startups, investors, and acquirers.
Three Core Modules for End-to-End M&A Intelligence
From market-wide acquisition tracking to personalized readiness scoring and board-ready outputs.
Industry Insights
Market-wide acquisition intelligence with hyper-filterable charts, graphs, and tables. Track deal activity by stage, sector, product type, amount paid, FDA pathway, acquirer, and acquisition rationale. Identify sector trends and valuation benchmarks across the medtech landscape.
User Insights
Personalized acquisition readiness insights based on your company profile. See how prepared you are to exit, benchmark your target valuation against real comparable acquisitions, identify the most likely buyers, and understand timing signals based on similar companies’ exit paths.
Board Deck Generator
Auto-generate board-ready PDF reports combining your profile data with market intelligence. Executive summaries, valuation comps, acquirer analysis, and strategic recommendations—structured for investor and board presentations.
Built for your role
Tailored M&A insights for founders, investors, and acquirers across the life sciences ecosystem.
For Founders
Navigate your exit strategy with data-driven confidence
- Track acquisition readiness score
- Benchmark valuation expectations
- Identify strategic acquirers
- Generate board-ready updates
For Investors
Monitor portfolio positioning and market dynamics
- Portfolio benchmarking
- Sector trend analysis
- Exit timing signals
- Valuation guidance
For Acquirers
Discover acquisition targets and pricing intelligence
- Target company discovery
- Deal size benchmarks
- Competitive intelligence
- Market momentum tracking